April 29, 2015. Many patients with higher-risk localized prostate cancer are treated with external beam radiation or with brachytherapy (seed implants). A clinical trial conducted by Dr James Miller (right) of Vancouver, Canada has found that patients receiving permanent implant brachytherapy “seeds” plus a boost of radiation have a better chance of long-term survival than those treated with higher dose-escalated external beam radiotherapy but without the implants.
April 23, 2015. African American men have the highest rates of prostate cancer incidence and mortality in the United States. For the past twenty years cancer researchers have worried about this and researched various causal factors. Now a large study suggests obesity may play an important role in what specialists in disparities in prostate cancer risk are calling the “African-American race effect.”
Compares Prostate Screening to Tuskegee Experiment
This post is archived from February 2000.
Otis W. Brawley M.D. is Director of the Office of Special Populations Research and Assistant Director, Office of Science Policy at the National Cancer Institute. When he worked at the Division of Cancer Prevention and Control (DCPC) at the National Cancer Institute, he was part of a team that developed and launched the Prostate Cancer Prevention Trial, an 18,000 man trial looking at screening and epidemiology of prostate cancer and at prevention of benign prostatic hyperplasia and prostate cancer. He also served as chief of the NCI intramural prostate cancer clinic.
New York, January 15 1998. African-American men have the highest rate of prostate cancer in the world and the lowest rate of survival. The head of the American Cancer Society (ACS), Charles J. McDonald, MD, says: “Black men in America are 1.5 times more likely to develop prostate cancer and are 2 to 3 times more likely to die of the disease than white men.”
Prostate cancer, particularly among African Americans, is “a disgraceful tragedy that needs immediate and drastic action,” says John R. Kelly, a board director of the American Cancer Society. The ACS has issued a National Blueprint for Action on prostate cancer, promising to spend $8 to $10 million annually. The following chart shows the gap widening between African American men and all other US men. Continue reading “African-American Prostate Cancer Crisis (ARCHIVES)”